CN
216-131-3
应用筛选条件
关键词:'216-131-3'
显示 1-30 共 49 条结果 关于 "216-131-3" 范围 技术文档
MILLIPLEX MAP Phospho Akt1/PKBa (Thr308) MAPmates, Assay Buffer 1
42-645 38 131 µL 1 tube
MILLIPLEX MAP Anti-phospho Akt1/PKBα
(Thr308), biotin (20X), Assay Buffer 1 44-645 n/a 131 µL 1 tube
MILLIPLEX MAP MCF-7 Cell Lysate: IGF
Stimulated 47-216 n/a ------
MILLIPLEX MAP Phospho IGF1R (pan Tyr) MAPmates
Beads (20X) 42-647 48 131 L 1 tube
MILLIPLEX® MAP Anti-phospho IGF1R
(pan Tyr), biotin (20X) 44-647 n/a 131 L 1 tube
MILLIPLEX® MAP MCF-7 Cell Lysate: IGF
Stimulated 47-216 n/a -------- 1 vial
MILLIPLEX MAP Phospho IRS1 MAPmates
IRS1 Beads (20X) 42-627 36 131 µL 1 tube
MILLIPLEX MAP Anti-phospho
IRS1, biotin (20X) 44-627 n/a 131 µL 1 tube
MILLIPLEX MAP MCF-7 Cell
Lysate: IGF Stimulated 47-216 n/a -------- 1 vial
Data Sheet - H5000
is assayed spectrophotometrically in a
2.57 ml reaction mixture containing 39 mM
triethanolamine, 216 mM D-glucose, 0.74 mM ATP,
7.8 mM MgCl2, 1.1 mM β–NADP, 2.5 units glucose-
6-phosphate dehydrogenase
Data Sheet - H6380
is assayed spectrophotometrically in a
2.57 ml reaction mixture containing 39 mM
triethanolamine, 216 mM D-glucose, 0.74 mM ATP,
7.8 mM MgCl2, 1.1 mM β–NADP, 2.5 units glucose-
6-phosphate dehydrogenase
Data Sheet - H4502
Fernández, R., et al., J. Gen. Microbiol., 131(10),
2705-2709 (1985).
2. Entian, K.-D., and Fröhlich, K.-U., J. Bacteriol.,
158(1), 29-35 (1984).
3. Easterby, J.S., and Rosemeyer, M.A., FEBS
XP725 Antibody Number-Lot Number 071M4826
277 278 279 280
3.5 209 210 211 212 233 234 235 236 257 258 259 260 281 282 283 284
3.6 213 214 215 216 237 238 239 240 261 262 263 264 285 286 287 288
4.1 289 290 291 292
Product Information Sheet - SE120084
N.W. ed., Clinical Guide to Laboratory
Tests, 3rd Edition, W.B. Saunders, Co.,
Philadelphia, 1995: 216-217.
18. USA Center for Disease Control/National Institute
of Health Manual, “Biosafety in Microbiological
Product Information Sheet - SE120049
., Clinical Guide to Laboratory Tests,
3rd Edition, W.B. Saunders, Co., (Philadelphia, PA:
1995) 216-217.
18. USA Center for Disease Control/National Institute
of Health Manual, “Biosafety in Microbiological
Periodic Acid-Schiff (PAS) Staining System Procedure
preparations. Arch Biochem 16:131, 1948
2. Sheehan DC, Hrapchak BB: Theory and Practice Histotechnology, 2nd ed. CV Mosby,
St. Louis, (MO), pp 52, 164–167, 1980
3. Culling CFA, Allison RT, Barr
Protocol: Rat/Mouse C-Peptide 2 ELISA Kit
15 µl 611 98% 702 100%
10 µl 413 99% 466 99%
5 µl 216 104% 231
Protocol- EZRMCP2-21K
835 100% 938 100%
15 µl 611 98% 702 100%
10 µl 413 99% 466 99%
5 µl 216 104% 231 99%
MEAN ±
S.D. (n = 3)
20 µl
Product Information - CSAA1
phosphatase 1α P7979 Signal Transduction P y n/d n/d
215 PTEN P7482 Signal Transduction P y n/d y
216 PTEN Clone:PTN-18 P3487 Signal Transduction M y y y
217
SGK (serum and glucorticoid inducible
LIGHT DIAGNOSTICS¿ SimulFluor® RSV/FLU A DFA KIT
Positivo por SimulFluor® RSV/Flu
A
20 4 23 1
Negativo por SimulFluor®
RSV/Flu A
2 216 0 250
Total 22 220 23 251
Sensibilidad relativa de la Muestra directa vs.
PKH Dye Reference Guide
determination of short- and long-term natural
killer cell activity. J.Immunol.Methods 1995;
185: 209-216.
77. Kemp RB: Cytotoxicity in an
anchorage-independent fibroblast cell line
measured by a combination
Inhibitor Sourcebook 3rd Edition
Bmx, IGF-1R, and Syk (IC50 = 131, 386, 591, and 887 nM, respectively).
1 mg
Aurora Kinase/Cdk Inhibitor 189406 {4-(5-Amino-1-(2,6-difluorobenzoyl)-1h-[1,2,4]
triazol-3-ylamino)-benzenesulfonamide}
Protocol- 03-0179-00
Ratio
# 1 143 5 230 30
# 2 140 4 227 39
# 3 131 4 210 30
# 4 133 3 216 41
# 5 188 4 307
Article: Evaluation of immunological parameters in pit bull terrier-type dogs with juvenile onset generalized demodicosis and age-matched healthy pit bull terrier-type dogs
mange. I. Experimental production of lesions using antilym-
phocyte serum. Vet Parasitol 1977; 3: 121–131.
6. Barta O, Waltman C, Oyekan PP et al. Lymphocyte transforma-
tion suppression caused by
Calbiochem Biologics 33.1
region greatly reduce the in vitro activation efficiency
(EC50 = 2.77 mM, 113 mM, and 131 mM for mutant
procaspase-3 with DAD, DDA, and ADD sequence,
respectively; EC50 = 4.5 mM for wild-type procaspase
SMC Plate-based Immunoassay Development Kit (5 plates)
Ratio
# 1 143 5 230 30
# 2 140 4 227 39
# 3 131 4 210 30
# 4 133 3 216 41
# 5 188 4 307
User Guide Equinox SOP Software 2.1 for Windows XP
........
.
ii — Indice
121
121
122
123
123
124
125
126
126
126
127
127
129
129
130
131
131
131
132
133
135
137
Capitolo 1
Installazione/configurazione del programma e della pompa
Calbiochem Biologics 30.2
Does
not recognize MMP-1, MMP-2, MMP-3, MMP-8,
MMP-9, or the latent form of MMP-13. Sensitivity:
7 pg/ml. Assay range: 32 – 2000 pg/ml.
Anti-MMP-13 (131-140), Human (Mouse)
Clone M31.387. Immunoaffinity-purified
Calbiochem Biologics 33.2
33 .216
VEGF Receptor 2/3 Tyrosine Kinase Inhibitor
(3-(Indole-3-yl)-4-(3,4,5-trimethoxyphenyl)-1H-pyrrole-2,5-dione)
A cell-permeable, potent and ATP-competitive inhibitor
of VEGFR-2 and -3 tyrosine
Antibody SourceBook, Sixth Edition, DIST version
human, mouse AM5� 100 µg €338
Anti-Bcl-x (Ab-1) (201-216) Rabbit pAb FS, IB, PS human, mouse, opossum, rat PC67 100 µg €319
Anti-Bcl-x (Ab-3) (150-169) Rabbit pAb IB; NOT FS, NOT IF, NOT IP,
NOT
Protocol- 03-0178-00
39
# 3 131 4 210 30
# 4 133 3 216 41
# 5 188 4 307 48
# 6 186 3 304 54
# 7 209 3 343 62
# 8 183 4 298 46
# 9 195
Calbiochem Biologics 29.3
Tyr279 and the 10T
Phospho-Specific ~47 kDa GSK-3β phosphorylated on Tyr216. Phosphorylation of
(Tyr279/216), GSK-3β on Tyr216 is increased in degenerating cortical neurons.
Human (Rabbit) Reacts with human
CoPrime®Biochromatography System
group Open user&group setting window 215 NO NO NO NO NO YES
Backup&Restore 216-Backup&Restore Save, delete, restore back-up 216 NO NO NO NO NO YES
AI scale&filter 217-AI scale&filter Scale & filter analog
XP725 Antibody List Lot 129K4831
Marker C5867 NA NA M y n/d n/d
192 Anti Cy3+Cy5 C0992 NA NA M
212 Pan Cytokeratin C2931 NA NA M y y y
216 Anti Cy3+Cy5 C0992 NA NA M
225 Dnase I D0188 NA NA P n/d n/d n/d
240 Anti Cy3+Cy5
XP725 Antibody List Lot 129K4830
Marker C5867 NA NA M y n/d n/d
192 Anti Cy3+Cy5 C0992 NA NA M
212 Pan Cytokeratin C2931 NA NA M y y y
216 Anti Cy3+Cy5 C0992 NA NA M
225 Dnase I D0188 NA NA P n/d n/d n/d
240 Anti Cy3+Cy5
XP725 Antibody List Lot 089K4791
Marker C5867 NA NA M y n/d n/d
192 Anti Cy3+Cy5 C0992 NA NA M
212 Pan Cytokeratin C2931 NA NA M y y y
216 Anti Cy3+Cy5 C0992 NA NA M
225 Dnase I D0188 NA NA P n/d n/d n/d
240 Anti Cy3+Cy5
1/2